Camp4 Therapeutics (CAMP) EPS (Basic) (2023 - 2026)
Camp4 Therapeutics (CAMP) reported EPS (Basic) of -$0.21 for Q1 2026, up 68.86% on a YoY basis from -$0.12 in Q1 2025, and up 50.49% sequentially from -$0.43 in Q4 2025.
Camp4 Therapeutics (CAMP) EPS (Basic) (2023 - 2026) Analysis & Trends
Camp4 Therapeutics (CAMP) has 4 years of EPS (Basic) data on file, last reported at -$0.21 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) rose 68.86% year-over-year to -$0.21; the trailing twelve-month figure through Mar 2026 stood at -$1.03 (up 68.11% YoY), and the FY2025 full-year result was -$4.16, up 83.26% from the prior year.
- EPS (Basic) improved to -$0.21 in Q1 2026, from -$0.43 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.21 in Q1 2026 to a low of -$42.65 in Q3 2024.
- A 4-year average of -$15.4 and a median of -$3.05 in 2024 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) tumbled 37.68% in 2024 and soared 98.79% in 2025, its largest moves.
- Tracing CAMP's EPS (Basic) over 4 years: stood at -$33.85 in 2023, then soared by 91.0% to -$3.05 in 2024, then jumped by 86.02% to -$0.43 in 2025, then jumped by 50.49% to -$0.21 in 2026.
- Business Quant data shows CAMP's EPS (Basic) at -$0.21 in Q1 2026, -$0.43 in Q4 2025, and -$0.52 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Camp4 Therapeutics | 174.35 Mn | 174.35 Mn | - | -0.21 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.21 |
| Dec 31, 2025 | -0.43 |
| Sep 30, 2025 | -0.52 |
| Jun 30, 2025 | -1.00 |
| Mar 31, 2025 | -0.68 |
| Dec 31, 2024 | -3.05 |
| Sep 30, 2024 | -42.65 |
| Jun 30, 2024 | -27.05 |
| Mar 31, 2024 | -28.98 |
| Dec 31, 2023 | -33.85 |
| Sep 30, 2023 | -30.98 |